Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsorsort icon State
01/09/2016 1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma CIM Registered outdated
01/02/2017 NeuroEPO in patients with Mild-Moderate Alzheimer's disease CIM Registered
01/02/2017 NeuroEPO in patients with Parkinson disease stage II-III CIM Registered
03/02/2017 Phase I/II trial with the mutein no alfa of IL-2 CIM Registered outdated
30/04/2018 Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) CIM Registered
28/11/2016 NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer CIM Registered
30/04/2017 Nimotuzumab-pancreatic cancer-adults-Phase IV. CIM Registered
05/10/2018 Nimotuzumab cold kit for the immunodiagnosis of solid tumors CIM Registered
03/08/2018 CIMAvax-EGF-Platelets-Adults- Lung Cancer CIM Registered
17/10/2018 CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial CIM Registered
08/08/2018 VSSP in metastasic renal cell carcinoma CIM Registered
09/07/2018 Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory CIM Registered
02/08/2018 NeuroEPO in stroke CIM Registered
28/12/2018 Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) CIM Registered outdated
22/10/2020 CIMAvax-EGF in patients at high risk of lung cancer CIM Registered outdated
11/08/2020 CIMAvax-EGF in Bladder cancer CIM Registered outdated
01/10/2020 Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. CIM Registered outdated
19/11/2020 NeuroEPO-Ataxia-Adults-Phase III CIM Registered outdated
11/03/2021 Phyisician Led CIMAvax-EGF lung biomarkers CIM Registered outdated
18/03/2021 Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults CIM Registered outdated